Malta - engleski - Medicines Authority

g.l. pharma gmbh schlossplatz 1, 8502 lannach, austria - potassium iodide - tablet - potassium iodide 65 mg - all other therapeutic products

Europska Unija - engleski - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol - asthma - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists. 

Europska Unija - engleski - EMA (European Medicines Agency)

teva pharma b.v. - docetaxel - carcinoma, non-small-cell lung; breast neoplasms; prostatic neoplasms - antineoplastic agents - breast cancerdocetaxel teva pharma monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.non-small-cell lung cancerdocetaxel teva pharma is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer after failure of prior chemotherapy.docetaxel teva pharma in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small-cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancerdocetaxel teva pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.

Europska Unija - engleski - EMA (European Medicines Agency)

1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Malta - engleski - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 20 mg - psychoanaleptics

Malta - engleski - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 40 mg - psychoanaleptics

Malta - engleski - Medicines Authority

1 a pharma gmbh - tadalafil - film-coated tablet - tadalafil 2.5 milligram(s) - urologicals

Malta - engleski - Medicines Authority

1 a pharma gmbh - tadalafil - film-coated tablet - tadalafil 5 milligram(s) - urologicals

Malta - engleski - Medicines Authority

1 a pharma gmbh - tadalafil - film-coated tablet - tadalafil 10 milligram(s) - urologicals

Malta - engleski - Medicines Authority

1 a pharma gmbh - tadalafil - film-coated tablet - tadalafil 20 milligram(s) - urologicals